16 October 2023
-
Court ruling empowers pharmacists in HIV/AIDS and TB treatment
SOUTH AFRICA —Pretoria High Court has ruled in favor of a program that allows specifically trained pharmacists to prescribe medication to HIV/AIDS and TB patients,…
-
Pfizer responds to lower COVID-19 drug demand with cost-cutting measures
USA — Pfizer has unveiled a cost-cutting strategy that includes staff layoffs and a significant reduction in expenses as the pharmaceutical giant grapples with decreased…
-
Bristol Myers Squibb to acquire Mirati Therapeutics, bolstering oncology portfolio
USA — Bristol Myers Squibb has entered into an agreement to acquire Mirati Therapeutics for US$4.8 billion, in a move aimed at solidifying its position…
-
Novo Nordisk halts clinical trial of diabetes drug due to positive kidney benefits
DENMARK — Novo Nordisk has announced the early termination of a significant clinical trial assessing the efficacy of its diabetes drug, Ozempic, after preliminary data…
-
Sudan conflict persists, triggering a health crisis in displacement camps
SUDAN — The Sudanese health system has reached a critical juncture after enduring nearly half a year of conflict. Within densely populated camps, the prevalence…
-
Kenyatta University School of Medicine Students set to begin clinical training at KUTRRH
KENYA — The first group of 100 Kenyatta University School of Medicine students is poised to enter the Kenyatta University Teaching, Referral and Research Hospital…
-
EMA recommends conditional approval for Pfizer’s Elrexfio in treating multiple myeloma
NETHERLANDS — The European Medicines Agency (EMA) announced on Friday that its drug advisory panel has endorsed a conditional marketing authorization for Pfizer’s Elrexfio (elranatamab)…